Task: Answer the multiple choice question.
Question: Which drug exhibits a -1.250\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. COC(=O)c1ccc2c(=O)n(CC3CCCO3)c(SCC(=O)Nc3ccccc3Cl)nc2c1
b. Cc1ccccc1C(=O)N/N=C1/SCC(=O)N1Cc1ccccc1
c. O=C(O)C1CCN(C(=O)c2ccccc2Cl)CC1
d. Cc1nc(C(C)N(C)Cc2nc(Cc3ccccc3F)no2)c(C)s1
e. Nc1nc(SCC(=O)N2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)n[nH]1
Answer: b. Cc1ccccc1C(=O)N/N=C1/SCC(=O)N1Cc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1C(=O)N/N=C1/SCC(=O)N1Cc1ccccc1
Cc1ccccc1C(=O)N/N=C1/SCC(=O)N1Cc1ccccc1
N-[(E)-(3-benzyl-4-oxo-1,3-thiazolidin-2-ylidene)amino]-2-methylbenzamide